Strain Differences in Sensitivity to the Promoting Effect of Sodium L‐Ascorbate in a Two‐stage Rat Urinary Bladder Carcinogenesis Model

Rat strain differences in sensitivity to the promoting effect of sodium L‐ascorbate (SA) on the development of urinary bladder tumors were investigated. In experiment 1, WS/Shi (WS), ODS/Shi‐od/od (ODS), and LEW/Crj (LEW) rats were initiated with 0.05%N‐butyl‐N‐(4‐hydroxybutyl)‐nitrosamine (BBN) in their drinking water and subsequently given basal Oriental MF diet (M) with or without a 5% SA supplement. In LEW rats the SA treatment increased the induction of neoplastic lesions in the urinary bladder, whereas WS and ODS animals proved unresponsive to its promoting effects. In experiment 2, WS and F344 rats were maintained on two kinds of commercial basal diets, M and CLEA CA‐1 (C), during administration of SA, since dietary factors can influence promoting effects. Feeding M during the promotion period in F344 rats yielded significantly more neoplastic lesions than feeding C, but in WS rats no such dietary influence was apparent. In experiment 3, strain differences in biosynthesis of α‐2u‐globulin (α2u‐g) were assessed because both α2u‐g in the urine and administration of sodium salts of organic acids such as SA have been reported to be involved in tumor promotion. Immunohistochemical analysis of renal tubules and Western blotting analysis of urine revealed the presence of α2u‐g in all three strains examined. These data suggest that differences in susceptibility to promotion are due to genetic factors rather than dietary factors and the ability to synthesize . α2u‐g.

[1]  S. Fukushima,et al.  Induction of CYP isoenzymes in various organs of rats by 3-methylcholanthrene or beta-naphthoflavone. , 1995, Cancer letters.

[2]  G. Hard.  Species comparison of the content and composition of urinary proteins. , 1995, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[3]  S. Fukushima,et al.  Lack of induction of epithelial cell proliferation by sodium saccharin and sodium L-ascorbate in the urinary bladder of NCI-black-Reiter (NBR) male rats. , 1994, Toxicology and applied pharmacology.

[4]  S. Cohen,et al.  A comparison of the effects of sodium saccharin in NBR rats and in intact and castrated male F344 rats. , 1994, Cancer letters.

[5]  S. Yamamoto,et al.  Severity of promotion by sodium salts of succinic acid in rat urinary bladder carcinogenesis correlates with sodium ion concentration under conditions of equal urinary pH. , 1993, Carcinogenesis.

[6]  M. Elwell,et al.  Influence of Dietary Protein Concentration on Severity of Nephropathy in Fischer-344 (F-344/N) Rats , 1993, Toxicologic pathology.

[7]  C. Chappel.  A review and biological risk assessment of sodium saccharin. , 1992, Regulatory toxicology and pharmacology : RTP.

[8]  A. Hagiwara,et al.  No promotion of urinary bladder carcinogenesis by sodium L-ascorbate in male ODS/Shi-od/od rats lacking L-ascorbic acid-synthesizing ability. , 1991, Carcinogenesis.

[9]  S. Cohen,et al.  A proposed role for silicates and protein in the proliferative effects of saccharin on the male rat urothelium. , 1991, Carcinogenesis.

[10]  T. Masuko,et al.  Strain Differences in Susceptibility to 2‐Acetylaminofluorene and Phenobarbital Promotion of Hepatocarcinogenesis: Immunohistocliemical Analysis of Cytochrome P‐450 Isozyme Induction by 2‐Acetylaminofluorene and Phenobarbital , 1989, Japanese journal of cancer research : Gann.

[11]  J. D. de Camargo,et al.  Strain Differences in Susceptibility to 2‐Acetylaminofluorene and Phenobarbital Promotion of Rat Hepatocarcinogenesis in a Medium‐term Assay System: Quantitation of Glutathione S‐Transferase P‐positive Foci Development , 1989, Japanese journal of cancer research : Gann.

[12]  Y. Hayashi,et al.  High Susceptibility of an Analbuminemic Congenic Strain of Rats with an F344 Genetic Background to Induced Bladder Cancer and Its Possible Mechanism , 1988, Japanese journal of cancer research : Gann.

[13]  S. Fukushima,et al.  Strain Differences in N‐Butyl‐N‐(4‐hydroxybutyl)nitrosamine Bladder Carcinogenesis in Rats , 1988, Japanese journal of cancer research : Gann.

[14]  R. Branch,et al.  Genetic predisposition to bladder cancer: ability to hydroxylate debrisoquine and mephenytoin as risk factors. , 1987, Cancer research.

[15]  Edwin Silverberg,et al.  Statistical and epidemiologic data on urologic cancer , 1987, Cancer.

[16]  S. Fukushima,et al.  Influences of strain and diet on the promoting effects of sodium L-ascorbate in two-stage urinary bladder carcinogenesis in rats. , 1987, Cancer research.

[17]  F. Horio,et al.  Ascorbic acid requirement for the induction of microsomal drug-metabolizing enzymes in a rat mutant unable to synthesize ascorbic acid. , 1986, The Journal of nutrition.

[18]  S. Fukushima,et al.  Roles of urinary sodium ion concentration and pH in promotion by ascorbic acid of urinary bladder carcinogenesis in rats. , 1986, Cancer research.

[19]  F. Horio,et al.  Requirement for ascorbic acid in a rat mutant unable to synthesize ascorbic acid. , 1985, The Journal of nutrition.

[20]  J. Pouysségur,et al.  Growth factor action and intracellular pH regulation in fibroblasts. Evidence for a major role of the Na+/H+ antiport. , 1984, The Journal of biological chemistry.

[21]  S. Fukushima,et al.  Promotion by ascorbic acid, sodium erythorbate and ethoxyquin of neoplastic lesions in rats initiated with N-butyl-N-(4-hydroxybutyl) nitrosamine. , 1984, Cancer letters.

[22]  S. Fukushima,et al.  Promoting effects of sodium L-ascorbate on two-stage urinary bladder carcinogenesis in rats. , 1983, Cancer research.

[23]  R. Tsien,et al.  Na+/H+ exchange and cytoplasmic pH in the action of growth factors in human fibroblasts , 1983, Nature.

[24]  S. Fukushima,et al.  Promoting effect of sodium o-phenylphenate and o-phenylphenol on two-stage urinary bladder carcinogenesis in rats. , 1983, Gan.

[25]  S. Fukushima,et al.  Differences in susceptibility to sodium saccharin among various strains of rats and other animal species. , 1983, Gan.

[26]  J. Aoki,et al.  Species variations in the metabolism of N-butyl-N-(4-hydroxybutyl) nitrosamine and related compounds in relation to urinary bladder carcinogenesis. , 1983, Gan.

[27]  S. Fukushima,et al.  HISTOPATHOLOGICAL ANALYSIS OF PRENEOPLASTIC CHANGES DURING N‐BUTYL‐N‐(4‐HYDROXYBUTYL)‐ NITROSAMINE‐INDUCED URINARY BLADDER CARCINOGENESIS IN RATS , 1982, Acta pathologica japonica.

[28]  S. Cohen,et al.  Promoting effect of saccharin and DL-tryptophan in urinary bladder carcinogenesis. , 1979, Cancer research.

[29]  N. Ito.  Early changes caused by N-butyl-N-(4-hydroxybutyl)nitrosamine in the bladder epithelium of different animal species. , 1976, Cancer research.

[30]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[31]  O. J. Dunn.  Multiple Comparisons among Means , 1961 .

[32]  J. H. Roe,et al.  THE DETERMINATION OF ASCORBIC ACID IN WHOLE BLOOD AND URINE THROUGH THE 2,4-DINITROPHENYLHYDRAZINE DERIVATIVE OF DEHYDROASCORBIC ACID , 1943 .

[33]  A. Yoshitake,et al.  Behavior of α2u-globulin accumulating in kidneys of male rats treated with d-limonene: Kidney-type α2u-globulin in the urine as a marker of d-limonene nephropathy , 1991 .

[34]  N Ito,et al.  Promotion of urinary bladder carcinogenesis in experimental animals. , 1989, Experimental pathology.

[35]  S. Fukushima,et al.  Assessment of L-ascorbic acid requirement for prolonged survival in ODS rats and their susceptibility to urinary bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine. , 1988, Cancer letters.

[36]  S. Fukushima,et al.  Sodium citrate: a promoter of bladder carcinogenesis. , 1986, Japanese journal of cancer research : Gann.

[37]  S. Fukushima,et al.  Membrane potential of rat urinary bladder epithelial cells. , 1983, The Japanese journal of physiology.

[38]  R. Hicks.  Multistage carcinogenesis in the urinary bladder. , 1980, British medical bulletin.